By targeting IL-17, which operates ‘upstream’ of both IL-1 and IL-6 and results in a reduction of neutrophil recruitment, several factors known to play major roles in ARDS would be inhibited [34]. The gene discussed is IL6; the disease is acute respiratory distress syndrome.